The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
post
The Startup’s Guide: 10 Must-Have CMC SOPs for Virtual Pharma in Phase 1
Read More
white-paper
The CMC Trap: How Chemistry, Manufacturing, and Controls Failures Derail Drug Development
Read More
post
FDA PreCheck Pilot: A Smarter, Infrastructure-Centered Alternative to Fast Track and Breakthrough Designations
Read More
infographic
The Business Case for Investing in CMC: Protecting Your Asset and Ensuring Success
Read More
Let's move from science to success.
Let’s Talk